[1] 谢丽娥,廖峭,单振刚,等.广州地区输血传播人类嗜T淋巴细胞病毒的风险研究[J].广东医学,2018,39(S1):175-177.
[2] 陈长荣,谢金镇,张永昌,等.厦门市无偿献血者HTLV感染情况及基因亚型分析[J].中国输血杂志,2012(12):1257-1261.
[3] MA Y,ZHENG S,WANG N.Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China[J].PLoS One,2013,8(6):e66795.
[4] 李文慧,李玲,刘忠.无偿献血者HTLV筛查研究进展[J].2017,30(3):231-234.
[5] 唐荣才,刘衍春,刘毅,等.南京地区街头无偿献血者中抗HTLV-Ⅰ/Ⅱ的初步调查[J].中国输血杂志,2003(6):404-405.
[6] 胡文佳,陈慧,朱绍汶,等.南京地区献血者HTLV感染情况初步调查[J].国际检验医学杂志,2018,39(3):351-353.
[7] NEWBOUND G C,ANDREWS J M,ROURKE J P,et al.Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes[J].J Virol,1996,70:2101-2106.
[8] KIKU A,OHATA Y,MATSUMOTO H,et al.Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma[J].Cancer,1997,79:269.
[9] PROIETTI F A,CARNEIRO-PROIETTI A B F,CATALAN-SOARES B C,et al.Global epidemiology of HTLV-Ⅰinfection and associated diseases[J].Oncogene,2005,24:6058-6068.
[10] WILLIAMS A E,FANG G,SLAMON D J,et al.Seroprevalence and epidemiological correlates of HTLV-Ⅰinfection in U.S.blood donors[J].Science,1988,240:643.
[11] PRINSZE F J,ZAAIJER H L.The outcome of donor screening for human T-cell lymphotropic virus infection in The Netherlands[J].Vox Sanguinis,2012,102(3):198-203.
[12] SAILLY J C,LEBRUN T,COUDEVILLE L.Cost-effective approach to the screening of HIV,HBV,HCV,HTLV in blood donors in France[J].Rev Epidemiol Sante Publique,1997,45(2):131-141.
[13] 徐冬峰,李海华,汤纯柳.宁德市无偿献血人群HTLV-Ⅰ/Ⅱ感染情况调查[J].中国输血杂志,2015,28(1):63-64.
[14] 林铁辉,许梅.莆田地区无偿献血人群HTLV-Ⅰ/Ⅱ感染调查与分析[J].中国输血杂志,2014,27(7):754-756.
[15] 周学勇,程卫芳,张云,等.安徽地区献血人群HTLV感染调查[J].中国输血杂志,2020,33(2):145-147.
[16] 刘一毅,单振刚,陆家海.珠三角地区无偿献血人群HTLV感染的横断面调查[J].热带医学杂志,2019(5):653-655,668. |